The Therapeutic Goods Administration's (TGA) warning covers the following glucagon-like peptide-1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and obesity: Semaglutide, sold as Ozempic, Wegovy Tirzepatide, sold as Mounjaro Dulaglutide, sold as Trulicity Liraglutide, sold as Saxenda The TGA said the products had the potential to cause an eye disorder called non-arteritic anterior ischaemic optic neuropathy (NAION)
The Role of Gut Health in Absorption Your gut is the gatekeeper of your health
Keeps your skin, hair & nails looking healthy & beautiful The benefits of Vitamin B12 is not only limited to keeping your insides healthy, it also can help cosmetically
This is a revolutionary shift from insurance-based bottlenecks, offering semaglutide prescriptions without insurance in a model that adapts to modern lifestyles and healthcare preferences
Manufactured by AdvaCare Pharma in ISO/HACCP-certified facilities, these gummies offer a convenient and tasty supplementary approach to supporting your body's metabolism
doi: 10.3389/fpsyt.2024.1295766 Received 17 September 2023 Accepted 22 January 2024 Published 09 February 2024 Volume 15 - 2024 Edited by Kiran Veer Sandhu, University College Cork, Ireland Reviewed by Hossein Dabiri, Shahid Beheshti University of Medical Sciences, Iran Sangyong Jung, CHA University, Republic of Korea Padhmanand Sudhakar, Kumaraguru College of Technology, India Updates Copyright 2024 Luqman, He, Hassan, Ullah, Zhang, Rashid Khan, Din, Ullah, Wang and Wang